IPP Bureau
Lilly to acquire Orna Therapeutics in deal valued at up to $2.4 billion
By IPP Bureau - February 10, 2026
The acquisition brings Lilly a novel in vivo cell therapy platform built around engineered circular RNA and proprietary lipid nanoparticles
Motorica showcases advanced prosthetics expertise at OPAI National Conference
By IPP Bureau - February 10, 2026
Motorica India conducted a specialised masterclass led by Shumaev, centred on real-life rehabilitation scenarios and personalised therapy programs before and after prosthetic fitting
India’s go-to diabetes test under scrutiny as new evidence flags major gaps
By IPP Bureau - February 10, 2026
The paper highlights how conditions common across India—including anemia, inherited hemoglobin disorders, and glucose-6-phosphate dehydrogenase (G6PD) deficiency—can significantly distort HbA1c readings
Roche BTK drug emerges as potential breakthrough in primary progressive MS
By IPP Bureau - February 10, 2026
Antara Senior Care launches second Chennai care home amid growing senior population
By IPP Bureau - February 10, 2026
The new OMR facility, located in Chennai’s medical hub, is close to leading hospitals and offers excellent road and air connectivity
Ajooni Biotech bags record Rs. 47.52 crore order
By IPP Bureau - February 10, 2026
The company has commissioned a new plant at Khanna (Punjab), which has begun commercial production
Entero Healthcare expands MedTech footprint with acquisition of Anand Chemiceutics
By IPP Bureau - February 10, 2026
Anand Chemiceutics serves over 1,500 laboratories, hospitals, and government institutions
Zydus Lifesciences reports strong Q3 & 9M FY26 growth
By IPP Bureau - February 10, 2026
Revenue from operations surged 30% year-on-year to Rs. 68,645 million
GSK India crosses Rs. 1,000 crore mark, key portfolios drive 8.1% topline growth
By IPP Bureau - February 10, 2026
Launched in August 2025, GSK India’s Oncology business is rapidly gaining momentum
Neuland Laboratories reports Rs 1,264.5 crore revenue for 9MFY26
By IPP Bureau - February 10, 2026
The revenues this quarter are in line with the outlook we envisaged for the year
Time Medical India unveils next-generation MRI platforms at IRIA 2026
By IPP Bureau - February 10, 2026
The unveiling marks Time Medical India’s entry into next-generation helium-free MRI technology
Jubilant Pharmova posts robust Q3, eyes Vision 2030 with sterile injectables drive
By IPP Bureau - February 09, 2026
The board highlighted ongoing investments in Radiopharma, CDMO Sterile Injectables, and CRDMO businesses
HCG reports robust Q3 & 9M FY26 growth, strengthening its lead in Indian oncology
By IPP Bureau - February 09, 2026
HCG clinicians contributing to one of the largest bodies of oncology research from India
Sai Life Sciences posts stellar Q3, revenue surges 27% YoY; PAT nearly doubles
By IPP Bureau - February 09, 2026
Capital expenditure stood at Rs. 405 crore to date against a planned Rs. 700 crore for FY26
DKSH Malaysia teams up with Pfizer to boost access to anti-infective therapies
By IPP Bureau - February 09, 2026
Pfizer’s anti-infectives portfolio includes both established therapies for moderate to severe infections and newer, clinically robust antimicrobial treatments
